TSH genetics involves common variants in genes like TSHR, PDE8B, and CAPZB that modestly influence baseline TSH levels. Genome-wide association studies show these SNPs account for only a small fraction of TSH variability. A consumer DNA test may indicate a tendency toward slightly higher or lower TSH, but it cannot diagnose thyroid dysfunction. Clinical assessment requires blood tests (TSH, fT3, fT4, antibodies) and symptom evaluation. The effect sizes are small; most carriers remain within the normal range. No evidence supports treating subclinical TSH deviations based solely on genetics. Lifestyle factors (iodine, selenium, stress) have a greater impact. Many direct-to-consumer reports overstate the significance. If you have symptoms or abnormal lab results, consult an endocrinologist. Evidence: GWAS/observational, not interventional. Caveat: no clinical utility for healthy individuals.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-7fe436a2cc57985824446831